← All stocks

Sarepta Therapeutics, Inc.

SRPT Net buying
CIK 0000873303 #2046 in the set updated 17 Sep 2026
Bought (120 mo)
$43.47M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$158.04M
$2.43M on a plan · $133.75M straight out of an exercise
Sold at will
$21.86M
17 of 98 sales
Net
−$114.57M
+$21.61M against sales at will

By person

30 insiders · 178 transactions
13.5×

Douglas S. Ingram holds 13.5 times base salary in stock. $15.82M of shares against $1.17M in salary for 2025.

Salary from the company's own proxy. The shares are what Douglas S. Ingram last reported holding, valued at $17.02, the price Common Stock was last bought or sold at on the open market here, on 12 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mahatme Sandesh
EVP, CFO & CBO
$50.87M (9) scheduled
−$50.87M
44,284
0.0419%
$753.71K
+131.7%
Howton David T
EVP, General Counsel
$43.31M (17) scheduled
−$43.31M
31,871
0.0302%
$542.44K
+906.0%
Chambers Michael Andrew
Director
$23.27M (14)
+$23.27M
311,569
0.2950%
$5.30M
+314.4%
INGRAM DOUGLAS S
Chief Executive Officer
$14.02M (12)
+$14.02M
929,391
0.8799%
$15.82M
Barry Richard
Director
$5.49M (7)
$18.77M (5)
−$13.28M
3,123,542
2.96%
$53.16M
0.0%
Cumbo Alexander
EVP, Chief Commercial Officer
$12.25M (8) scheduled
−$12.25M
12,008
0.0114%
$204.38K
−40.8%
Wigzell Hans Lennart Rudolf
Director
$11.03M (15) scheduled
−$11.03M
42,098
0.0399%
$716.51K
+643.0%
Brown Ryan Edward
EVP, General Counsel
$6.55M (8) scheduled
−$6.55M
17,129
0.0162%
$291.54K
+286.5%
Kaye Edward M. MD
Director
$4.04M (5) scheduled
−$4.04M
71,229
0.0674%
$1.21M
−7.5%
Arif Bilal
Chief Tech Ops Officer
$2.18M (8) scheduled
−$2.18M
32,500
0.0308%
$553.15K
+37.5%
Ruff Shamim
SVP, Chief Regulatory Affairs
$2.09M (6) scheduled
−$2.09M
31,936
0.0302%
$543.55K
+85.3%
Aphale Jayant
VP, Technical Operations
$1.75M (2) scheduled
−$1.75M
11,490
0.0109%
$195.56K
0.0%
BEHRENS M KATHLEEN
Director
$219.95K (1)
$1.75M (2) scheduled
−$1.53M
224,357
0.2124%
$3.82M
+85.2%
Estepan Ian Michael
Chief Operating Officer
$1.27M (3)
−$1.27M
177,184
0.1677%
$3.02M
+1,225%
Mayo Stephen
Director
$603.00K (3)
−$603.00K
18,640
0.0176%
$317.25K
Bratica Joseph
Principal Financial Officer
$538.35K (3) scheduled
−$538.35K
8,140
0.0077%
$138.54K
0.0%
Murray Dallan
Chief Customer Officer
$508.90K (1) scheduled
−$508.90K
38,202
0.0362%
$650.20K
+74.0%
Rodino-Klapac Louise
President, R&D and Tech Ops
$299.87K (1)
+$299.87K
203,900
0.1930%
$3.47M
+2,430%
Boor Kathryn Jean
Director
$298.95K (2)
−$298.95K
25,138
0.0238%
$427.85K
Nicaise Claude
Director
$248.20K (1) scheduled
−$248.20K
48,407
0.0458%
$823.89K
+4,741%
BONNEY MICHAEL W
Director
$173.48K (1)
+$173.48K
9,126
0.0086%
$155.32K
SEVERINO MICHAEL
Chief Executive Officer
756,104
0.7158%
$12.87M
Wong Ryan Ho-Yan
Chief Financial Officer
121,792
0.1153%
$2.07M
+589.8%
Rothfuss Cristin
EVP, General Counsel
115,519
0.1094%
$1.97M
+738.4%
O'Neill Gilmore Neil
EVP, R&D & CMO
29,070
0.0275%
$494.77K
Connelly Deirdre P
Director
22,100
0.0209%
$376.14K
Ciambrone William
EVP
22,099
0.0209%
$376.12K
+8,432%
GRAY MARY ANN
Director
12,356
0.0117%
$210.30K
+18,071%
MARTIN JOHN C
Director
7,913
0.0075%
$134.68K
Kress Jean-Paul
Director
2,000
0.0019%
$34.04K
+100.0%
Insider
Date
Role
Action
Shares
Price
Amount
Nicaise Claude
12 Mar 2025
Director
Sold after exercise
2,491
$99.64
$248.20K
Wigzell Hans Lennart Rudolf
12 Dec 2024
Director
Sold after exercise
10,500
$124.84
$1.31M
Brown Ryan Edward
25 Jun 2024
EVP, General Counsel
Sold after exercise
2,549
$164.52
$419.36K
Brown Ryan Edward
25 Jun 2024
EVP, General Counsel
Sold after exercise
3,840
$163.53
$627.96K
Brown Ryan Edward
25 Jun 2024
EVP, General Counsel
Sold after exercise
17,581
$162.65
$2.86M
Brown Ryan Edward
25 Jun 2024
EVP, General Counsel
Sold after exercise
4,168
$161.82
$674.47K
Brown Ryan Edward
25 Jun 2024
EVP, General Counsel
Sold after exercise
975
$160.31
$156.30K
Brown Ryan Edward
25 Jun 2024
EVP, General Counsel
Sold after exercise
2,200
$159.14
$350.11K
Brown Ryan Edward
25 Jun 2024
EVP, General Counsel
Sold after exercise
7,644
$158.07
$1.21M
Wigzell Hans Lennart Rudolf
8 Mar 2024
Director
Sold after exercise
100
$122.39
$12.24K
Wigzell Hans Lennart Rudolf
8 Mar 2024
Director
Sold after exercise
11,745
$123.10
$1.45M
Wigzell Hans Lennart Rudolf
8 Mar 2024
Director
Sold after exercise
3,155
$123.85
$390.75K
Wigzell Hans Lennart Rudolf
4 Aug 2023
Director
Sold after exercise
15,000
$106.72
$1.60M
BEHRENS M KATHLEEN
10 Mar 2021
Director
Sold after exercise
5,000
$85.76
$428.80K
Wigzell Hans Lennart Rudolf
8 Mar 2021
Director
Sold after exercise
10,000
$83.51
$835.10K
Bratica Joseph
11 Dec 2020
Principal Financial Officer
Sold after exercise
1,115
$165.00
$183.98K
Bratica Joseph
8 Dec 2020
Principal Financial Officer
Sold after exercise
1,125
$160.00
$180.00K
Wigzell Hans Lennart Rudolf
10 Aug 2020
Director
Sold after exercise
777
$159.65
$124.05K
Wigzell Hans Lennart Rudolf
10 Aug 2020
Director
Sold after exercise
9,223
$158.95
$1.47M
Bratica Joseph
3 Aug 2020
Principal Financial Officer
Sold after exercise
1,125
$155.00
$174.38K
Howton David T
22 Jun 2020
EVP, General Counsel
Sold after exercise
55,270
$171.50
$9.48M
Howton David T
22 Jun 2020
EVP, General Counsel
Sold after exercise
35,757
$170.59
$6.10M
Howton David T
22 Jun 2020
EVP, General Counsel
Sold after exercise
8,086
$169.56
$1.37M
Howton David T
22 Jun 2020
EVP, General Counsel
Sold after exercise
6,009
$168.61
$1.01M
Wigzell Hans Lennart Rudolf
20 May 2020
Director
Sold after exercise
854
$151.77
$129.61K
Wigzell Hans Lennart Rudolf
20 May 2020
Director
Sold after exercise
2,046
$151.22
$309.40K
Wigzell Hans Lennart Rudolf
20 May 2020
Director
Sold after exercise
2,100
$149.62
$314.20K
Wigzell Hans Lennart Rudolf
4 Mar 2020
Director
Sold after exercise
5,000
$116.89
$584.45K
Mahatme Sandesh
13 Dec 2019
EVP, CFO & CBO
Sold after exercise
125,000
$125.50
$15.69M
Howton David T
13 Dec 2019
EVP, General Counsel
Sold after exercise
78,000
$125.50
$9.79M
Cumbo Alexander
13 Dec 2019
EVP, Chief Commercial Officer
Sold after exercise
9,294
$125.50
$1.17M
Cumbo Alexander
13 Dec 2019
EVP, Chief Commercial Officer
Sold after exercise
32,706
$125.50
$4.10M
Howton David T
22 Nov 2019
EVP, General Counsel
Sold after exercise
2,957
$105.00
$310.49K
Howton David T
22 Nov 2019
EVP, General Counsel
Sold after exercise
3,753
$105.00
$394.07K
Howton David T
22 Nov 2019
EVP, General Counsel
Sold after exercise
18,290
$105.00
$1.92M
Wigzell Hans Lennart Rudolf
23 May 2019
Director
Sold after exercise
10,000
$120.00
$1.20M
Mahatme Sandesh
7 Feb 2019
EVP, CFO & CBO
Sold after exercise
65,000
$145.00
$9.43M
Howton David T
1 Feb 2019
SVP, General Counsel
Sold after exercise
30,000
$140.00
$4.20M
Cumbo Alexander
1 Feb 2019
SVP, Chief Commercial Officer
Sold after exercise
15,000
$140.00
$2.10M
Mahatme Sandesh
31 Jan 2019
EVP, CFO & CBO
Sold after exercise
21,198
$130.72
$2.77M
Mahatme Sandesh
30 Jan 2019
EVP, CFO & CBO
Sold after exercise
43,802
$130.00
$5.69M
Wigzell Hans Lennart Rudolf
1 Nov 2018
Director
Sold after exercise
6,667
$140.50
$936.71K
BEHRENS M KATHLEEN
31 Oct 2018
Director
Sold after exercise
10,000
$131.71
$1.32M
Mahatme Sandesh
24 Oct 2018
EVP, CFO & CBO
Sold after exercise
107,524
$127.74
$13.74M
Howton David T
16 Jul 2018
SVP, General Counsel
Sold after exercise
37,848
$136.46
$5.16M
Howton David T
16 Jul 2018
SVP, General Counsel
Sold after exercise
9,056
$136.46
$1.24M
Howton David T
16 Jul 2018
SVP, General Counsel
Sold after exercise
3,096
$136.46
$422.48K
Cumbo Alexander
9 Jul 2018
SVP, Chief Commercial Officer
Sold after exercise
11,914
$137.32
$1.64M
Cumbo Alexander
9 Jul 2018
SVP, Chief Commercial Officer
Sold after exercise
9,944
$137.32
$1.37M
Cumbo Alexander
9 Jul 2018
SVP, Chief Commercial Officer
Sold after exercise
11,924
$137.32
$1.64M
Wigzell Hans Lennart Rudolf
30 Nov 2017
Director
Sold after exercise
6,667
$55.89
$372.62K
Ruff Shamim
6 Nov 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
10,000
$55.00
$550.00K
Ruff Shamim
3 Oct 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
11,500
$50.00
$575.00K
Ruff Shamim
21 Jul 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
1,500
$44.00
$66.00K
Ruff Shamim
21 Jul 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
4,388
$44.00
$193.07K
Cumbo Alexander
20 Jul 2017
SVP, Chief Commercial Officer
Sold after exercise
3,418
$41.00
$140.14K
Cumbo Alexander
20 Jul 2017
SVP, Chief Commercial Officer
Sold after exercise
2,500
$41.00
$102.50K
Howton David T
20 Jul 2017
SVP, General Counsel
Sold after exercise
5,944
$41.00
$243.70K
Howton David T
20 Jul 2017
SVP, General Counsel
Sold after exercise
19,056
$41.00
$781.30K
Ruff Shamim
20 Jul 2017
SVP, Regulatory Affairs & Qual
Sold after exercise
6,250
$42.00
$262.50K
Mahatme Sandesh
20 Jul 2017
EVP, CFO & CBO
Sold after exercise
7,627
$41.00
$312.71K
Mahatme Sandesh
20 Jul 2017
EVP, CFO & CBO
Sold after exercise
32,998
$41.00
$1.35M
Mahatme Sandesh
20 Jul 2017
EVP, CFO & CBO
Sold after exercise
9,375
$41.00
$384.38K
Mahatme Sandesh
17 Oct 2016
Senior Vice President, CFO
Sold after exercise
30,000
$50.08
$1.50M
Howton David T
22 Sep 2016
SVP, General Counsel
Sold after exercise
7,000
$60.00
$420.00K
Kaye Edward M. MD
22 Sep 2016
President, CEO & CMO
Sold after exercise
40,179
$60.00
$2.41M
Ruff Shamim
22 Sep 2016
SVP, Regulatory Affairs & Qual
Sold after exercise
7,311
$60.00
$438.66K
Howton David T
19 Sep 2016
SVP, General Counsel
Sold after exercise
1,304
$50.00
$65.20K
Howton David T
19 Sep 2016
SVP, General Counsel
Sold after exercise
8,000
$50.00
$400.00K
Kaye Edward M. MD
19 Sep 2016
President, CEO & CMO
Sold after exercise
10,405
$50.00
$520.25K
Kaye Edward M. MD
19 Sep 2016
President, CEO & CMO
Sold after exercise
947
$50.00
$47.35K
Kaye Edward M. MD
19 Sep 2016
President, CEO & CMO
Sold after exercise
13,000
$50.00
$650.00K
Aphale Jayant
19 Sep 2016
VP, Technical Operations
Sold after exercise
25,000
$50.00
$1.25M
Aphale Jayant
19 Sep 2016
VP, Technical Operations
Sold after exercise
10,000
$50.00
$500.00K

What was left out

Form 4 filings counted 336
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 74
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 5,025,891
Sales filed before the plan box existed 7
History held since 2 Sep 2016